Cargando…

Trypanosoma vivax is the second leading cause of camel trypanosomosis in Sudan after Trypanosoma evansi

BACKGROUND: This study was conducted in response to recurring reports from eastern Sudan of camel trypanosomosis that can no longer be treated by currently available trypanocidal drugs. One hundred and eighty-nine blood samples were obtained from camels in different herds and local markets in the we...

Descripción completa

Detalles Bibliográficos
Autores principales: Mossaad, Ehab, Salim, Bashir, Suganuma, Keisuke, Musinguzi, Peter, Hassan, Mohammed A., Elamin, E. A., Mohammed, G. E., Bakhiet, Amel O., Xuan, Xuenan, Satti, Rawan A., Inoue, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390396/
https://www.ncbi.nlm.nih.gov/pubmed/28403897
http://dx.doi.org/10.1186/s13071-017-2117-5
_version_ 1782521451136417792
author Mossaad, Ehab
Salim, Bashir
Suganuma, Keisuke
Musinguzi, Peter
Hassan, Mohammed A.
Elamin, E. A.
Mohammed, G. E.
Bakhiet, Amel O.
Xuan, Xuenan
Satti, Rawan A.
Inoue, Noboru
author_facet Mossaad, Ehab
Salim, Bashir
Suganuma, Keisuke
Musinguzi, Peter
Hassan, Mohammed A.
Elamin, E. A.
Mohammed, G. E.
Bakhiet, Amel O.
Xuan, Xuenan
Satti, Rawan A.
Inoue, Noboru
author_sort Mossaad, Ehab
collection PubMed
description BACKGROUND: This study was conducted in response to recurring reports from eastern Sudan of camel trypanosomosis that can no longer be treated by currently available trypanocidal drugs. One hundred and eighty-nine blood samples were obtained from camels in different herds and local markets in the western part of Sudan, and a cross-sectional study was carried out between December 2015 and February 2016 to identify the causative agents and possible circulating genotypes. RESULTS: The prevalence of trypanosomes detected using the conventional parasitological techniques of Giemsa-stained blood smears, wet blood smears and the microhematocrit centrifugation technique (MHCT) was 7% (13/189), 11% (21/189) and 19% (36/189), respectively. However, a multi-species KIN-PCR targeting the ITS region revealed that the prevalence of Trypanosoma evansi was 37% (70/189), while that of T. vivax was 25% (47/189). Consequently, we used a T. evansi-specific PCR (RoTat1.2 VSG gene) to analyse the KIN-PCR-positive samples and a T. vivax-specific PCR (Cathepsin L-like gene) to analyse all of the samples. The prevalence of T. evansi was 59% (41/70), while the prevalence of T. vivax was 31% (59/189). Mixed infections were detected in 18% (34/189) of the samples. These results were further confirmed by sequencing and a phylogenetic analysis of the complete internal transcribed spacer (ITS) region of T. evansi and the TviCatL gene of T. vivax. CONCLUSION: We conclude that T. vivax was newly introduced to the camel population and that T. evansi is no longer the single cause of camel trypanosomosis in Sudan. The presence of T. vivax in camels detected in this study is a challenge in the choice of diagnostic approaches, particularly serology, and PCRs. However, an analysis of drug resistance should be performed, and the genotypic variation should be verified. To our knowledge, this is the first molecular study on T. vivax and mixed-infection with T. vivax and T. evansi in Sudanese camels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-017-2117-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5390396
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53903962017-04-14 Trypanosoma vivax is the second leading cause of camel trypanosomosis in Sudan after Trypanosoma evansi Mossaad, Ehab Salim, Bashir Suganuma, Keisuke Musinguzi, Peter Hassan, Mohammed A. Elamin, E. A. Mohammed, G. E. Bakhiet, Amel O. Xuan, Xuenan Satti, Rawan A. Inoue, Noboru Parasit Vectors Research BACKGROUND: This study was conducted in response to recurring reports from eastern Sudan of camel trypanosomosis that can no longer be treated by currently available trypanocidal drugs. One hundred and eighty-nine blood samples were obtained from camels in different herds and local markets in the western part of Sudan, and a cross-sectional study was carried out between December 2015 and February 2016 to identify the causative agents and possible circulating genotypes. RESULTS: The prevalence of trypanosomes detected using the conventional parasitological techniques of Giemsa-stained blood smears, wet blood smears and the microhematocrit centrifugation technique (MHCT) was 7% (13/189), 11% (21/189) and 19% (36/189), respectively. However, a multi-species KIN-PCR targeting the ITS region revealed that the prevalence of Trypanosoma evansi was 37% (70/189), while that of T. vivax was 25% (47/189). Consequently, we used a T. evansi-specific PCR (RoTat1.2 VSG gene) to analyse the KIN-PCR-positive samples and a T. vivax-specific PCR (Cathepsin L-like gene) to analyse all of the samples. The prevalence of T. evansi was 59% (41/70), while the prevalence of T. vivax was 31% (59/189). Mixed infections were detected in 18% (34/189) of the samples. These results were further confirmed by sequencing and a phylogenetic analysis of the complete internal transcribed spacer (ITS) region of T. evansi and the TviCatL gene of T. vivax. CONCLUSION: We conclude that T. vivax was newly introduced to the camel population and that T. evansi is no longer the single cause of camel trypanosomosis in Sudan. The presence of T. vivax in camels detected in this study is a challenge in the choice of diagnostic approaches, particularly serology, and PCRs. However, an analysis of drug resistance should be performed, and the genotypic variation should be verified. To our knowledge, this is the first molecular study on T. vivax and mixed-infection with T. vivax and T. evansi in Sudanese camels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-017-2117-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-13 /pmc/articles/PMC5390396/ /pubmed/28403897 http://dx.doi.org/10.1186/s13071-017-2117-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mossaad, Ehab
Salim, Bashir
Suganuma, Keisuke
Musinguzi, Peter
Hassan, Mohammed A.
Elamin, E. A.
Mohammed, G. E.
Bakhiet, Amel O.
Xuan, Xuenan
Satti, Rawan A.
Inoue, Noboru
Trypanosoma vivax is the second leading cause of camel trypanosomosis in Sudan after Trypanosoma evansi
title Trypanosoma vivax is the second leading cause of camel trypanosomosis in Sudan after Trypanosoma evansi
title_full Trypanosoma vivax is the second leading cause of camel trypanosomosis in Sudan after Trypanosoma evansi
title_fullStr Trypanosoma vivax is the second leading cause of camel trypanosomosis in Sudan after Trypanosoma evansi
title_full_unstemmed Trypanosoma vivax is the second leading cause of camel trypanosomosis in Sudan after Trypanosoma evansi
title_short Trypanosoma vivax is the second leading cause of camel trypanosomosis in Sudan after Trypanosoma evansi
title_sort trypanosoma vivax is the second leading cause of camel trypanosomosis in sudan after trypanosoma evansi
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390396/
https://www.ncbi.nlm.nih.gov/pubmed/28403897
http://dx.doi.org/10.1186/s13071-017-2117-5
work_keys_str_mv AT mossaadehab trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi
AT salimbashir trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi
AT suganumakeisuke trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi
AT musinguzipeter trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi
AT hassanmohammeda trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi
AT elaminea trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi
AT mohammedge trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi
AT bakhietamelo trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi
AT xuanxuenan trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi
AT sattirawana trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi
AT inouenoboru trypanosomavivaxisthesecondleadingcauseofcameltrypanosomosisinsudanaftertrypanosomaevansi